APA (7th ed.) Citation

Kreuter, M., Vansteenkiste, J. F., Fischer, J., Eberhardt, W. E. E., Zabeck, H., Kollmeier, J., . . . Thomas, M. (2016). Three-year follow-up of a randomized phase II trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine (the TREAT study). Journal of thoracic oncology, 11(1), . https://doi.org/10.1016/j.jtho.2015.09.014

Chicago Style (17th ed.) Citation

Kreuter, Michael, et al. "Three-year Follow-up of a Randomized Phase II Trial on Refinement of Early-stage NSCLC Adjuvant Chemotherapy with Cisplatin and Pemetrexed Versus Cisplatin and Vinorelbine (the TREAT Study)." Journal of Thoracic Oncology 11, no. 1 (2016). https://doi.org/10.1016/j.jtho.2015.09.014.

MLA (9th ed.) Citation

Kreuter, Michael, et al. "Three-year Follow-up of a Randomized Phase II Trial on Refinement of Early-stage NSCLC Adjuvant Chemotherapy with Cisplatin and Pemetrexed Versus Cisplatin and Vinorelbine (the TREAT Study)." Journal of Thoracic Oncology, vol. 11, no. 1, 2016, https://doi.org/10.1016/j.jtho.2015.09.014.